JOHNSON & JOHNSON
578.2B
·Mkt Cap
23.2x
·P/E
$239.99
+$2.20 (+0.93%)
Johnson & Johnson and its subsidiaries (the Company) have approximately 138,100 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the healthcare field. Johnson & Johnson is a holding company, with operating companies conducting business in virtually all countries of the world. The Company’s primary focus is products related to human health and well-being. Johnson & Johnson was incorporated in the State of New Jersey in 1887. The Chief Operating Decision Maker (CODM) is the Company's Chief Executive Officer (Principal Executive Officer). The Executive Committee is Johnson & Johnson’s senior leadership team responsible for setting the strategy and priorities of the Company and driving accountability at all levels. Within the strategic parameters provided by the Executive Committee, senior management groups at U.S.
| Metric | 2017 | 2018 | 2019 | 2021 | 2022 | |||
|---|---|---|---|---|---|---|---|---|
| Earnings Power | ||||||||
| Revenue | 71.9B | 81.6B | 82.1B | 82.6B | 93.8B | 80.0B | 88.8B | 92.1B |
| Net Income | 16.5B | 15.3B | 15.1B | 14.7B | 20.9B | 17.9B | 14.1B | 25.1B |
| Owner Earnings | 14.1B | 14.3B | 15.4B | 15.3B | 14.9B | 13.1B | 15.8B | 15.7B |
| Non-Recurring | 491M | 251M | 266M | 247M | 252M | 275M | 234M | 234M |
| Gross Margin | 69.7% | 66.8% | 66.4% | 65.6% | 68.2% | 69.3% | 69.1% | 68.1% |
| Op. Margin | 28.6% | -1.7% | -3.1% | -3.5% | 24.5% | 26.5% | -5.3% | 8.5% |
| Net Margin | 23.0% | 18.8% | 18.4% | 17.8% | 22.3% | 22.4% | 15.8% | 27.3% |
| Returns on Capital | ||||||||
| ROE | 27.5% | 25.6% | 25.4% | 23.3% | 28.2% | 26.1% | 11.8% | 31.7% |
| ROA | 10.5% | 10.0% | 9.6% | 8.4% | 11.5% | 10.7% | 8.1% | 13.0% |
| ROIC | 22.4% | 17.5% | 17.6% | 15.3% | 27.6% | 24.2% | 13.8% | 22.9% |
| Cash Flow | ||||||||
| Free Cash Flow | 15.5B | 18.5B | 19.9B | 20.2B | 19.8B | 17.2B | 19.8B | 19.6B |
| CapEx | 3.2B | 3.7B | 3.5B | 3.3B | 3.7B | 4.0B | 4.4B | 4.6B |
| Maint. CapEx | 3.8B | 6.9B | 7.0B | 7.2B | 7.4B | 7.0B | 7.3B | 7.3B |
| Growth CapEx | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx/OCF | 17.2% | 16.5% | 14.9% | 14.2% | 15.6% | 18.9% | 18.2% | 19.0% |
| D&A | 3.8B | 6.9B | 7.0B | 7.2B | 7.4B | 7.0B | 7.3B | 7.3B |
| Capital Allocation | ||||||||
| Op. Cash Flow | 18.8B | 22.2B | 23.4B | 23.5B | 23.4B | 21.2B | 24.3B | 24.2B |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0 |
| Share Buybacks | 9.0B | 5.9B | 6.7B | 3.2B | 3.5B | 6.0B | 2.4B | 2.4B |
| Buyback Yield | 2.9% | 2.1% | 2.0% | 0.8% | 0.8% | 1.5% | 0.7% | 0.4% |
| Debt Repayment | 2.2B | 1.6B | 2.8B | 1.1B | 1.8B | 2.1B | 1.5B | 1.5B |
| Stock-Based Comp | 878M | 978M | 977M | 1.0B | 1.1B | 1.1B | 1.2B | 1.2B |
| Balance Sheet | ||||||||
| Total Assets | 157.3B | 153.0B | 157.7B | 174.9B | 182.0B | 167.6B | 180.1B | 192.8B |
| Intangibles | 85.1B | 78.1B | 81.3B | 89.8B | 81.6B | 70.7B | 81.8B | 81.8B |
| Total Liabilities | 97.1B | 93.2B | 98.3B | 111.6B | 108.0B | 98.8B | 108.6B | 113.5B |
| Equity | 60.2B | 59.8B | 59.5B | 63.3B | 74.0B | 68.8B | 71.5B | 79.3B |
| Net Debt | 16.3B | 10.8B | 8.4B | 10.1B | 2.1B | 6.4B | 12.1B | 27.2B |
| Long-Term Debt | 30.7B | 27.7B | 26.5B | 32.6B | 30.0B | 25.9B | 30.7B | N/A |
| Debt/Equity | 0.57 | 0.51 | 0.47 | 0.56 | 0.46 | 0.43 | 0.51 | 0.58 |
| Interest Coverage | 28.3 | -1.4 | -7.9 | -14.4 | 125.5 | 76.8 | -6.2 | -6.2 |
| Working Capital | 12.6B | 14.8B | 9.3B | 8.7B | 15.8B | 7.2B | 5.6B | 5.6B |
| Current Assets | 43.1B | 46.0B | 45.3B | 51.2B | 61.0B | 53.5B | 55.9B | 55.9B |
| Current Liabilities | 30.5B | 31.2B | 36.0B | 42.5B | 45.2B | 46.3B | 50.3B | 50.3B |
| Retained Earnings | 101.8B | 106.2B | 110.7B | 113.9B | 123.1B | 153.8B | 155.8B | 155.8B |
| Per Share Data | ||||||||
| Avg. Price | 102.28 | 107.82 | 112.18 | 145.06 | 155.31 | 148.57 | 148.56 | 239.99 |
| EPS | 5.93 | 5.61 | 5.63 | 5.51 | 7.81 | 6.73 | 5.79 | 10.35 |
| Owner EPS | 5.07 | 5.24 | 5.75 | 5.73 | 5.57 | 4.91 | 6.48 | 6.51 |
| Book Value | 21.57 | 21.91 | 22.15 | 23.70 | 27.69 | 25.80 | 29.43 | 32.90 |
| Cash Flow/Share | 6.73 | 8.14 | 8.72 | 8.81 | 8.76 | 7.95 | 9.99 | 13.47 |
| Dividends/Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 2.8B | 2.7B | 2.7B | 2.7B | 2.7B | 2.7B | 2.4B | 2.4B |
| Valuation | ||||||||
| P/E Ratio | 19.0 | 18.6 | 21.9 | 27.5 | 20.6 | 21.9 | 24.3 | 23.2 |
| Price/Book | 5.2 | 4.8 | 5.6 | 6.4 | 5.8 | 5.7 | 4.8 | 7.3 |
| Price/Sales | 4.0 | 3.6 | 3.7 | 4.7 | 4.4 | 5.0 | 4.1 | 6.3 |
| EV/EBIT | 16.1 | N/A | N/A | N/A | 18.9 | 18.8 | N/A | 77.1 |
| FCF Yield | 5.0% | 6.5% | 6.0% | 5.0% | 4.6% | 4.4% | 5.8% | 3.4% |
| Market Cap | 313.6B | 285.1B | 330.6B | 404.6B | 431.1B | 392.6B | 341.9B | 578.2B |
| Year-End Price | 112.42 | 104.55 | 123.10 | 151.52 | 161.26 | 147.27 | 140.74 | 239.99 |